Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one‐year randomized controlled trial comparing systematic versus on‐demand treatment

Maxime Bréban, Philippe Ravaud, Pascal Claudepierre, Gabriel Baron, Yves‐Dominique Henry, Christophe Hudry, Liana Euller‐Ziegler, Thao Pham, Elisabeth Solau‐Gervais, Isabelle Chary‐Valckenaere,

Arthritis & Rheumatism · 2007 · 135 citations · 33 references

DOIFull text

Open access

Abstract

These findings indicate that continuous treatment of AS with infliximab is more efficacious than on-demand treatment, and that the addition of MTX to infliximab provides no significant benefit.

References

33